Management of children prescribed psychostimulant medication for attention deficit hyperactivity disorder in the Hunter region of NSW

Medical Journal of Australia

Volumn 165, Issue 9, 1996, Pages 477-480

  Hazell, Philip L ^a,b,d   McDowell, Michael J ^a,c   Walton, Jane M ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Wallsend Hospital Campus   (Australia)

^c Royal Children's Hospital and Health Service District   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOSTIMULANT AGENT;

AFFECTIVE NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; BEHAVIOR DISORDER; CLINICAL TRIAL; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MINIMAL BRAIN DYSFUNCTION; PRACTICE GUIDELINE; QUALITY OF LIFE; RETROSPECTIVE STUDY;

EID: 0029961417     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb138611.x     Document Type: Article

References (17)

1. Hazell P. Stimulant treatment for attention deficit-hyperactivity disorder. Aust Prescriber 1995; 18: 60-63.
2. Storm V, Hutchins P, Nguyen R. When there needs to be more than psychotherapy: changes in the pattern of stimulant use for NSW children with ADHD: 1988-1994 Abstracts of the 30th Congress of the Royal Australian and New Zealand College of Psychiatrists, 1995 May 8; Cairns (Qld). Melbourne: RANZCP, 1995: 20.
3. Gadow KD. Prevalence of drug therapy. In: Werry JS, Aman MG. editors. Practitioner's guide to psychoactive drugs for children and adolescents. New York: Plenum Medical. 1993: 57-74
4. National Health and Medical Research Council. Attention deficit hyperactivity disorder (ADHD) [consultation document]. Canberra: NHMRC, 1996.
5. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1991; 30: I-III.
6. Gadow KD. Attention deficit disorder and hyperactivity. Pharmacotherapies. In: Matson JL, editor. Handbook of treatment approaches in childhood psychopathology New York: Plenum Press, 1988: 215-247.
7. Barkley RA. Attention deficit hyperactivity disorder. A handbook for diagnosis and treatment. New York: Guilford Press, 1990.
8. Ruel J-M, Hickey CP. Are too many children being treated with methylphenidate? Can J Psychiatry 1992; 37: 570-572.
9. Wolraich ML, Lindgren S, Stromquist A, et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 1990; 86: 95-101.
10. Dixon WJ, editor. BMDP statistical software. Berkeley (CA): University of California Press, 1988.
11. Levy F, Ward PB. Neurometrics, dynamic brain imaging and attention deficit hyperactivity disorder. J Paed Child Health 1995; 31: 279-283.
12. Johnston C, Fine S. Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction and compliance. J Ped Psychol 1993; 18: 717-730.
13. Anderson JC, Williams S, McGee R, Silva P. DSM-III disorders in preadolescent children. Arch Gen Psychiatry 1987; 44: 69-76.
14. Bird HR, Canino G, Rubio-Stipec M, et al. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. Arch Gen Psychiatry 1988; 45: 1120-1126.
15. McGee R, Share DL. Attention deficit disorder-hyperactivity and academic failure: which comes first and what should be treated? J Am Acad Child Adolesc Psychiatry 1988; 27: 318-325.
16. McGee R, Feehan M, Williams S, et al. DSM-III disorders in a large sample of adolescents J Am Acad Child Adolesc Psychiatry 1990; 29: 611-619.
17. Szatmari P, Boyle M, Offord DR. ADDH and conduct disorder: degree of diagnostic overlap and differences among correlates. J Am Acad Child Adolesc Psychiatry 1989; 28: 865-872.